Steven Quay
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Steven Quay
Steven Quay is recorded as CEO at Atossa Therapeutics, Inc. (ATOS). The proxy statement of Atossa Therapeutics, Inc. reports total compensation of $2,502,856 for Steven Quay in fiscal 2025, including a base salary of $730,961. Disclosed compensation is on record for 8 fiscal years. Steven Quay has spoken on 1 earnings call across 1 company, most recently for Atossa Therapeutics, Inc. on August 14, 2023.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Atossa Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Greg Weaver CFO
- Mark Daniel CFO, Chief Accounting Officer
- Mark J. Daniel CFO
- Dr. Tessa Cigler, M.D., M.P.H. Board Member
- H. Lawrence Remmel, Esq. Board Member
- Jonathan Finn Board Member
- Jonathan Finn, CFA Board Member
- Shu-Chih Chen Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Atossa Therapeutics, Inc. (ATOS) | M.D., Ph. D. Chief Executive Officer | $730,961 | $2,502,856 |
| 2024 | Atossa Therapeutics, Inc. (ATOS) | M.D., Ph. D. Executive Officer | $705,910 | $2,764,082 |
| 2023 | Atossa Therapeutics, Inc. (ATOS) | M.D., Ph. D. Executive Officer | $705,910 | $2,356,220 |
| 2022 | Atossa Therapeutics, Inc. (ATOS) | M.D. Ph. D. Executive Officer | $705,910 | $3,160,876 |
| 2021 | Atossa Therapeutics, Inc. (ATOS) | MD., Ph.D. Executive Officer | $659,000 | $5,892,563 |
| 2020 | Atossa Therapeutics, Inc. (ATOS) | MD., Ph.D. Executive Officer | $600,624 | $2,936,284 |
| 2019 | Atossa Therapeutics, Inc. (ATOS) | MD., Ph.D. President and Chief Executive Officer | $600,624 | $5,807,923 |
| 2018 | Atossa Therapeutics, Inc. (ATOS) | MD., Ph.D. President and Chief Executive Officer | $582,000 | $2,172,344 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.